FDA Drug Application (204251) for SIMBRINZA by ALCON RES LTD

Back to FDA Applications sponsored by ALCON RES LTD

Application Number204251
Product Number001
FormSUSPENSION/DROPS;OPHTHALMIC
Dosage0.2%;1%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSIMBRINZA
Active IngredientBRIMONIDINE TARTRATE; BRINZOLAMIDE

Active IngredientCount
List of drugs with Active Ingredient BRIMONIDINE TARTRATE8
List of drugs with Active Ingredient BRINZOLAMIDE2


Back to FDA Applications sponsored by ALCON RES LTD